All 258 BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Holdings
There are 258 BIB holdings. Top 10 companies weight: 60.91%.
Total Market Cap: $1.73T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (258 stocks) | +18.25% | 21.12 | 15.77 | 0.45 | +26.32% | +9.60% | 0.75 | ||||||||||
151 | XERS | Xeris Biopharma Holdings Inc | 0.05% | $8.78 | $1.50B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 121.84 | 107.53 | N/A | N/A | N/A | 75 | +28.59% | $11 | +20.06% | 1.02 |
152 | INBX | Inhibrx Biosciences Inc | 0.05% | $87.61 | $1.33B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +216.74% | $278 | 0.00% | 1.39 |
153 | JANX | Janux Therapeutics Inc Ordinary Shares | 0.04% | $16.26 | $976M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 70 | +128.72% | $37 | -11.75% | 1.20 |
154 | KURA | Kura Oncology Inc | 0.04% | $10.89 | $1.01B | Biotechnology | Healthcare | +15.40% | N/A | N/A | N/A | N/A | N/A | 76 | +186.23% | $31 | -10.12% | 1.06 |
155 | PCRX | Pacira Biosciences Inc | 0.04% | $25.78 | $996M | Drug Manufacturers - Specialty & Generic | Healthcare | -47.75% | 191.22 | 8.74 | 11.21 | N/A | N/A | 58 | +15.09% | $30 | -14.99% | 0.31 |
156 | XNCR | Xencor Inc | 0.04% | $20.45 | $1.11B | Biotechnology | Healthcare | +10.21% | N/A | 68.03 | N/A | N/A | N/A | 76 | +38.53% | $28 | -8.77% | 1.43 |
157 | WVE | Wave Life Sciences Ltd | 0.04% | $5.79 | $1.14B | Biotechnology | Healthcare | -19.81% | N/A | N/A | N/A | N/A | N/A | 78 | +278.93% | $22 | -2.17% | 1.46 |
158 | VOR | Vor Biopharma Inc Ordinary Shares | 0.04% | $20.05 | $980M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +88.93% | $38 | -41.06% | 1.24 |
159 | ANNX | Annexon Inc Ordinary Shares | 0.04% | $5.39 | $1.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +176.07% | $15 | -24.51% | 1.22 |
160 | ALVO | Alvotech | 0.04% | $3.52 | $1.12B | Drug Manufacturers - Specialty & Generic | Healthcare | -18.97% | N/A | 7.91 | N/A | N/A | N/A | 60 | +314.77% | $15 | 0.00% | 0.80 |
161 | MRVI | N/A | 0.04% | $7.10 | $451M | Biotechnology | Healthcare | N/A | N/A | 370.37 | N/A | N/A | N/A | 65 | -16.90% | $5.90 | -29.84% | 1.21 |
162 | ABUS | Arbutus Biopharma Corp | 0.04% | $4.52 | $898M | Biotechnology | Healthcare | N/A | 5.60 | 10.25 | N/A | N/A | N/A | 75 | +14.60% | $5.18 | +9.97% | 0.89 |
163 | OLMA | N/A | 0.04% | $11.59 | $1.03B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +251.16% | $41 | -14.19% | 0.72 |
164 | ORIC | Oric Pharmaceuticals Inc | 0.04% | $10.83 | $1.15B | Biotechnology | Healthcare | -10.25% | N/A | N/A | N/A | N/A | N/A | 76 | +87.35% | $20 | -9.37% | 1.45 |
165 | CGEM | Cullinan Therapeutics Inc | 0.04% | $18.06 | $1.10B | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +74.70% | $32 | -7.12% | 1.06 |
166 | ETON | Eton Pharmaceuticals Inc | 0.04% | $43.20 | $1.05B | Drug Manufacturers - Specialty & Generic | Healthcare | -38.49% | N/A | 62.50 | N/A | N/A | N/A | 75 | +14.00% | $49 | +49.99% | 0.87 |
167 | SLDB | Solid Biosciences Inc | 0.04% | $8.46 | $947M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +106.86% | $18 | -28.03% | 1.77 |
168 | REPL | Replimune Group Inc | 0.04% | $11 | $801M | Biotechnology | Healthcare | +16.21% | N/A | N/A | N/A | N/A | N/A | 56 | -3.00% | $11 | -19.74% | 0.74 |
169 | EYPT | Eyepoint Inc | 0.04% | $13.05 | $1.16B | Biotechnology | Healthcare | +6.42% | N/A | 6.16 | N/A | N/A | N/A | 81 | +210.34% | $41 | +9.74% | 1.25 |
170 | DSGN | Design Therapeutics Inc | 0.04% | $12.06 | $844M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +74.13% | $21 | -7.33% | 1.13 |
171 | SANA | Sana Biotechnology Inc Ordinary Shares | 0.04% | $3.16 | $958M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +171.20% | $8.57 | -29.67% | 1.98 |
172 | BIOA | Bioage Labs Inc | 0.04% | $22.65 | $1.01B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +118.54% | $50 | 0.00% | 1.04 |
173 | SPRY | Ars Pharmaceuticals Inc | 0.03% | $6.36 | $750M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +320.60% | $27 | -28.22% | 1.16 |
174 | CSTL | Castle Biosciences Inc | 0.03% | $24.51 | $728M | Diagnostics & Research | Healthcare | -7.41% | N/A | N/A | N/A | N/A | N/A | 75 | +74.54% | $43 | -18.53% | 0.85 |
175 | AURA | Aura Biosciences Inc | 0.03% | $7.03 | $430M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +167.43% | $19 | 0.00% | 1.11 |
176 | TRAX | First Tracks Biotherapeutics Inc | 0.03% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
177 | CADL | Candel Therapeutics Inc | 0.03% | $10.22 | $706M | Biotechnology | Healthcare | N/A | N/A | 43.48 | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
178 | RGNX | Regenxbio Inc | 0.03% | $10.34 | $633M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +134.72% | $24 | -22.65% | 1.83 |
179 | GERN | Geron Corp | 0.03% | $1.44 | $951M | Biotechnology | Healthcare | -18.28% | N/A | N/A | N/A | N/A | N/A | 66 | +136.11% | $3.40 | +2.22% | 1.16 |
180 | FDMT | N/A | 0.03% | $11.38 | $611M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +148.09% | $28 | -14.22% | 1.22 |
181 | PAHC | Phibro Animal Health Corp Class A | 0.03% | $33.86 | $1.37B | Drug Manufacturers - Specialty & Generic | Healthcare | +15.27% | 13.83 | 13.83 | 0.03 | N/A | N/A | 50 | +34.67% | $46 | +9.27% | 1.16 |
182 | PRME | Prime Medicine Inc | 0.03% | $3.12 | $630M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +128.21% | $7.12 | 0.00% | 2.10 |
183 | CTMX | Cytomx Therapeutics Inc | 0.03% | $3.42 | $652M | Biotechnology | Healthcare | N/A | 24.82 | 14.20 | 0.76 | N/A | N/A | 83 | +265.50% | $13 | -9.49% | 2.01 |
184 | CRMD | Cormedix Inc | 0.03% | $8.19 | $660M | Biotechnology | Healthcare | N/A | 3.63 | 16.50 | N/A | N/A | N/A | 90 | +83.15% | $15 | +4.99% | 0.84 |
185 | ESPR | Esperion Therapeutics Inc | 0.03% | $3.18 | $799M | Drug Manufacturers - Specialty & Generic | Healthcare | -31.57% | N/A | 4.64 | N/A | N/A | N/A | N/A | N/A | N/A | -28.31% | N/A |
186 | RIGL | Rigel Pharmaceuticals Inc | 0.03% | $39.31 | $758M | Biotechnology | Healthcare | N/A | 6.87 | 9.01 | N/A | N/A | N/A | 65 | +37.88% | $54 | -1.22% | 1.10 |
187 | ALLO | Allogene Therapeutics Inc | 0.03% | $1.85 | $465M | Biotechnology | Healthcare | -14.18% | N/A | N/A | N/A | N/A | N/A | 76 | +386.49% | $9 | -39.19% | 1.53 |
188 | TBPH | Theravance Biopharma Inc | 0.03% | $16.84 | $872M | Biotechnology | Healthcare | N/A | 12.26 | 7.91 | N/A | N/A | N/A | 55 | +4.93% | $18 | +4.12% | 0.53 |
189 | ZVRA | Zevra Therapeutics Inc | 0.03% | $12.45 | $766M | Biotechnology | Healthcare | N/A | 5.89 | 11.93 | 10.67 | N/A | N/A | 80 | +124.02% | $28 | +2.53% | 0.65 |
190 | IRWD | Ironwood Pharmaceuticals Inc Class A | 0.03% | $3.91 | $658M | Drug Manufacturers - Specialty & Generic | Healthcare | -12.17% | 8.62 | 12.33 | N/A | N/A | N/A | 68 | +62.40% | $6.35 | -21.35% | 1.07 |
191 | GRFS | Grifols Sa Adr | 0.03% | $7.75 | $4.91B | Drug Manufacturers - General | Healthcare | -10.20% | 10.11 | 8.40 | 0.08 | N/A | N/A | 62 | +40.26% | $11 | -12.03% | 0.85 |
192 | MESO | Mesoblast Ltd Adr | 0.03% | $16.42 | $2.36B | Biotechnology | Healthcare | -15.82% | N/A | 454.55 | N/A | N/A | N/A | 91 | +113.15% | $35 | +2.75% | 1.39 |
193 | AMPH | Amphastar Pharmaceuticals Inc | 0.03% | $19.59 | $866M | Drug Manufacturers - Specialty & Generic | Healthcare | +101.37% | 11.27 | N/A | 2.77 | N/A | N/A | 42 | +12.30% | $22 | -0.82% | 0.70 |
194 | ACRS | Aclaris Therapeutics Inc | 0.03% | $5.69 | $782M | Biotechnology | Healthcare | -15.62% | N/A | N/A | N/A | N/A | N/A | 75 | +75.75% | $10 | -18.28% | 0.86 |
195 | PHAT | N/A | 0.03% | $11.25 | $878M | Biotechnology | Healthcare | -24.73% | N/A | N/A | N/A | N/A | N/A | 77 | +110.67% | $24 | -19.21% | 1.26 |
196 | OMER | Omeros Corp | 0.03% | $9.53 | $747M | Biotechnology | Healthcare | N/A | 9.26 | 58.14 | 0.81 | N/A | N/A | 58 | +246.27% | $33 | -7.72% | 1.37 |
197 | EOLS | Evolus Inc | 0.02% | $5.81 | $392M | Drug Manufacturers - Specialty & Generic | Healthcare | -30.42% | N/A | 50.51 | N/A | N/A | N/A | 75 | +152.71% | $15 | -12.27% | 1.17 |
198 | RCKT | Rocket Pharmaceuticals Inc | 0.02% | $3.40 | $398M | Biotechnology | Healthcare | -5.96% | N/A | N/A | N/A | N/A | N/A | 53 | +176.18% | $9.39 | -41.34% | 1.35 |
199 | ARVN | Arvinas Inc | 0.02% | $8.26 | $534M | Biotechnology | Healthcare | +1.07% | N/A | 17.86 | N/A | N/A | N/A | N/A | N/A | N/A | -37.19% | N/A |
200 | CABA | Cabaletta Bio Inc Ordinary Shares | 0.02% | $2.82 | $463M | Biotechnology | Healthcare | +8.20% | N/A | N/A | N/A | N/A | N/A | 72 | +374.47% | $13 | -19.26% | 1.66 |
BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Sector Allocation
HEALTHCARE
53.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%